AAM
AGN

Aberdeen Asset Management’s Allergan Inc AGN Stock Holding History

Aberdeen Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-97,964
Closed -$20.8M – 714
2014
Q4 		$20.8M Sell
97,964
-3,494
-3% -$695K 0.05% 183
2014
Q3 		$18.1M Buy
101,458
+1,006
+1% +$167K 0.04% 225
2014
Q2 		$17M Buy
100,452
+69,151
+221% +$10.8M 0.04% 249
2014
Q1 		$3.88M Hold
31,301
– – 0.01% 228
2013
Q4 		$3.45M Hold
31,301
– – 0.01% 233
2013
Q3 		$2.83M Sell
31,301
-3,880
-11% -$348K 0.01% 242
2013
Q2 		$2.96M Buy
+35,181
New +$3.65M 0.01% 230

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Aberdeen Asset Management's AGN Position: Q1 2015 in Review

Aberdeen Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 97,964 shares — an estimated $20.8M sold.

Aberdeen Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $20.8M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Aberdeen Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Aberdeen Asset Management sold 97,964 Allergan Inc shares in Q1 2015, an estimated $20.8M.
  • Aberdeen Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Aberdeen Asset Management's Allergan Inc position peaked at $20.8M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Aberdeen Asset Management's 13F filing for Q1 2015, filed 11 May 2015.